Showing results (151-160 of 494) with videos related to

Sort By:
Pageof 50
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 13, 2020
Prognosis of Patients With Stage III Melanoma According to American Joint Committee on Cancer Version 8: A Reassessment on the Basis of 3 Independent Stage III Melanoma CohortsClaus Garbe, Ulrike Keim, Stefan Suciu, et al.
Molecular & Cellular Proteomics : MCP|October 21, 2021
Proteogenomics Reveals Perturbed Signaling Networks in Malignant Melanoma Cells Resistant to BRAF InhibitionMarisa Schmitt, Tobias Sinnberg, Katrin Bratl, et al.
Plos Medicine|June 6, 2008
Improving melanoma classification by integrating genetic and morphologic featuresAmaya Viros, Jane Fridlyand, Juergen Bauer, et al.
Psychotherapie, Psychosomatik, Medizinische Psychologie|February 20, 2013
[Acceptance and reliability of an electronic psychooncological screening of patients with breast cancer: a randomized controlled study]Norbert Schäffeler, Karoline Pfeiffer, Eva Maria Grischke, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|January 20, 2011
Oncogenetics of melanoma: basis for molecular diagnostics and therapyLaura Held, Thomas K Eigentler, Friedegund Meier, et al.
Acta Dermato-Venereologica|May 26, 2020
Indirect Comparison of Combined BRAF and MEK Inhibition in Melanoma Patients with Elevated Baseline Lactate DehydrogenaseValerie Glutsch, Teresa Amaral, Claus Garbe, et al.
Acta Dermato-Venereologica|November 10, 2020
Diagnostic Accuracy of Electrical Impedance Spectroscopy in Non-melanoma Skin CancerEsra Sarac, Andreas Meiwes, Thomas Eigentler, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 20, 2015
Influence of (18)F-FDG PET/CT on therapy management in patients with stage III/IV malignant melanomaSusann-Cathrin Schüle, Thomas Kurt Eigentler, Claus Garbe, et al.
Virchows Archiv : an International Journal of Pathology|November 9, 2018
BRAF mutation testing in melanoma: results from a German observational multicenter studyArndt Hartmann, Peter Schirmacher, William Sterlacci, et al.
Cancers|November 13, 2021
Individualized Proteogenomics Reveals the Mutational Landscape of Melanoma Patients in Response to ImmunotherapyMarisa Schmitt, Tobias Sinnberg, Heike Niessner, et al.
Pageof 50